Phase III trials of Covid-19 drug Movfor show positive results, confirms Hetero

Phase III trials of Covid-19 drug Movfor show positive results, confirms Hetero

No fatalities were reported during the study, it added. Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine. The results, presented as an Oral Abstract at the Conference on Retroviruses and Opportunistic Infections (CROI) held virtually February 12–16, 2022, demonstrated that Molnupiravir along … Read more

Promote traditional medicine with data, clinical trial studies, and research papers: IMA chief

coronil

Coronil was launched as Covid-19 drug by Patanjali Ayurved in the presence of Union ministers (Image: Patanjali Ayurved twitter) The Indian Medical Association (IMA) which has been in the news for its sharp reaction to the launch of Patanjali Ayurved’s Coronil drug for COVID in the presence of Union ministers, clarifies that it is not … Read more